Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:37 AM
Ignite Modification Date:
2025-12-25 @ 1:37 AM
NCT ID:
NCT00382694
Eligibility Criteria:
Inclusion Criteria:
* Multiple myeloma, stage I-III, previously untreated, and eligible for induction therapy followed by high dose treatment supported by autologous stem cell transplantation.
Exclusion Criteria:
* Severe uncontrolled clinical or microbiological evidence of infection at the time of enrolment.
* Other active malignancy.
* Severe coincident heart or lung disease including uncontrolled hypertension, unstable angina, congestive heart failure, coronary angioplasty within six months, myocardial infarction within the last six months, or uncontrolled cardiac arrhythmia.
* Other severe illness including poorly controlled diabetes.
* Haemolytic anaemia (Coombs positive without evidence of haemolysis is accepted).
* Idiopathic thrombocytopenic purpura.
* Terminal illness.
* Allogenic transplantation planned within 6 months.
* Chemotherapy before inclusion.
* Pregnancy or breast-feeding, or inadequate contraceptive precautions.
* Psychiatric disease, abuse of alcohol or narcotics, or any other disorder that might compromise the patients ability to give informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
64 Years
Study:
NCT00382694
Study Brief:
Protocol Section:
NCT00382694